S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Best Bear Market Funds: Top 3 Investment Options to Consider
Low VIX? 3 High Beta Stocks To Boost Your Returns
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Best Bear Market Funds: Top 3 Investment Options to Consider
Low VIX? 3 High Beta Stocks To Boost Your Returns
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Best Bear Market Funds: Top 3 Investment Options to Consider
Low VIX? 3 High Beta Stocks To Boost Your Returns
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Best Bear Market Funds: Top 3 Investment Options to Consider
Low VIX? 3 High Beta Stocks To Boost Your Returns
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
NASDAQ:TSVT

2seventy bio (TSVT) Stock Price, News & Analysis

$5.38
+0.42 (+8.47%)
(As of 03/27/2024 ET)
Today's Range
$4.81
$5.40
50-Day Range
$3.09
$6.00
52-Week Range
$1.53
$12.69
Volume
1.10 million shs
Average Volume
1.54 million shs
Market Capitalization
$276.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.33

2seventy bio MarketRank™ Stock Analysis

Analyst Rating
Hold
2.38 Rating Score
Upside/​Downside
147.8% Upside
$13.33 Price Target
Short Interest
Healthy
11.13% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.07mentions of 2seventy bio in the last 14 days
Based on 6 Articles This Week
Insider Trading
Acquiring Shares
$3.14 M Bought Last Quarter
Proj. Earnings Growth
Growing
From ($1.36) to $0.11 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.10 out of 5 stars

Medical Sector

375th out of 939 stocks

Pharmaceutical Preparations Industry

172nd out of 422 stocks

TSVT stock logo

About 2seventy bio Stock (NASDAQ:TSVT)

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and chimeric antigen receptor-T cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

TSVT Stock Price History

TSVT Stock News Headlines

Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
2seventy bio's (TSVT) "Neutral" Rating Reaffirmed at Wedbush
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
A Preview Of 2seventy bio's Earnings
TSVT Mar 2024 2.500 put
TSVT Jun 2024 5.000 put
See More Headlines
Receive TSVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 2seventy bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/05/2024
Today
3/28/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TSVT
Fax
N/A
Employees
425
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$13.33
High Stock Price Target
$26.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+147.8%
Consensus Rating
Hold
Rating Score (0-4)
2.38
Research Coverage
8 Analysts

Profitability

Net Income
$-217,570,000.00
Net Margins
-216.73%
Pretax Margin
-216.73%

Debt

Sales & Book Value

Annual Sales
$100.39 million
Book Value
$5.04 per share

Miscellaneous

Free Float
49,977,000
Market Cap
$276.05 million
Optionable
Optionable
Beta
1.84
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives


TSVT Stock Analysis - Frequently Asked Questions

Should I buy or sell 2seventy bio stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for 2seventy bio in the last twelve months. There are currently 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" TSVT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TSVT, but not buy additional shares or sell existing shares.
View TSVT analyst ratings
or view top-rated stocks.

What is 2seventy bio's stock price target for 2024?

8 Wall Street research analysts have issued 12-month target prices for 2seventy bio's shares. Their TSVT share price targets range from $5.00 to $26.00. On average, they expect the company's share price to reach $13.33 in the next twelve months. This suggests a possible upside of 147.8% from the stock's current price.
View analysts price targets for TSVT
or view top-rated stocks among Wall Street analysts.

How have TSVT shares performed in 2024?

2seventy bio's stock was trading at $4.27 at the beginning of the year. Since then, TSVT stock has increased by 26.0% and is now trading at $5.38.
View the best growth stocks for 2024 here
.

When is 2seventy bio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our TSVT earnings forecast
.

How were 2seventy bio's earnings last quarter?

2seventy bio, Inc. (NASDAQ:TSVT) posted its earnings results on Tuesday, March, 5th. The company reported ($1.11) EPS for the quarter, beating the consensus estimate of ($1.22) by $0.11. The company had revenue of $10.68 million for the quarter, compared to the consensus estimate of $13.91 million. 2seventy bio had a negative trailing twelve-month return on equity of 59.19% and a negative net margin of 216.73%. During the same quarter in the prior year, the firm earned ($0.60) earnings per share.

What ETFs hold 2seventy bio's stock?
Who are 2seventy bio's major shareholders?

2seventy bio's stock is owned by many different retail and institutional investors. Top institutional investors include Goldman Sachs Group Inc. (8.91%), Goldman Sachs Group Inc. (8.91%), Vanguard Group Inc. (7.87%), Vanguard Group Inc. (7.77%), Madison Avenue Partners LP (3.47%) and Engine Capital Management LP (2.95%). Insiders that own company stock include Casdin Capital, Llc, Kynam Capital Management, Lp, Nick Leschly, Nicola Heffron, Philip D Gregory and William D Baird III.
View institutional ownership trends
.

How do I buy shares of 2seventy bio?

Shares of TSVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TSVT) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners